AN2 Therapeutics, Inc. (ANTX) Earnings
NASDAQ·Healthcare·Biotechnology
$4.76
+6.85%
Mkt Cap $131.53M
EPS — Estimate vs Actual
Mkt Cap
$131.53M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.10
NASDAQ·Healthcare·Biotechnology
$4.76
+6.85%
Mkt Cap $131.53M
Mkt Cap
$131.53M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.10